Epstein-Barr virus turns 50

Science

Volumn 343, Issue 6177, 2014, Pages 1323-1325

  Lieberman, Paul M ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; EPSTEIN BARR VIRUS VACCINE; VIRUS PROTEIN; HERPES VACCINE;

CANCER; CARCINOGEN; TUMOR; VACCINE; VIRUS; WORLD HEALTH ORGANIZATION;

CANCER EPIDEMIOLOGY; CANCER IMMUNIZATION; CARCINOGENESIS; CHILDHOOD CANCER; DNA TUMOR VIRUS; EPSTEIN BARR VIRUS; HUMAN; INFECTION PREVENTION; MEDICATION THERAPY MANAGEMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINE PRODUCTION; ANIMAL; ARTICLE; BURKITT LYMPHOMA; EPSTEIN BARR VIRUS INFECTION; GENETICS; IMMUNOLOGY; NEOPLASM; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRUS GENOME; VIRUS LATENCY;

ANIMALS; BURKITT LYMPHOMA; CARCINOGENESIS; EPSTEIN-BARR VIRUS INFECTIONS; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HERPESVIRUS VACCINES; HUMANS; NEOPLASMS; VIRUS LATENCY;

EID: 84897005439     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1252786     Document Type: Review

References (15)

1. M. A. Epstein, B. G. Achong, Y. M. Barr, Lancet 283, 702 (1964).
2. P. K. Pattengale, R. W. Smith, P. Gerber, Lancet 302, 93 (1973).
3. Y. Chang et al., Science 266, 1865 (1994).
4. D. M. Parkin, Int. J. Cancer 118, 3030 (2006).
5. R. Baer et al., Nature 310, 207 (1984).
6. M. H. Tsai et al., Cell Rep. 5, 458 (2013).
7. L. S. Young, A. B. Rickinson, Nat. Rev. Cancer 4, 757 (2004).
8. N. Raab-Traub, Curr. Opin. Virol. 2, 453 (2012).
9. D. A. Thorley-Lawson, M. J. Allday, Nat. Rev. Microbiol. 6, 913 (2008).
10. J. T. Schiller, P. Davies, Nat. Rev. Microbiol. 2, 343 (2004).
11. E. M. Sokal et al., J. Infect. Dis. 196, 1749 (2007).
12. C. M. Bollard, C. M. Rooney, H. E. Heslop, Nat. Rev. Clin. Oncol. 9, 510 (2012).
13. D. H. Dreyfus, Autoimmun. Rev. 11, 88 (2011).
14. H. Varmus, H. S. Kumar, Sci. Transl. Med. 5, 175cm172 (2013).
15. J. I. Cohen, A. S. Fauci, H. Varmus, G. J. Nabel, Sci. Transl. Med. 3, 107fs107 (2011).